BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wentao Wang, Yaxun Guo, Jingtao Zhong, Qi Wang, Xin Wang, Honglong Wei, Jie Li, Peng Xiu. The clinical significance of microvascular invasion in the surgical planning and postoperative sequential treatment in hepatocellular carcinoma. Sci Rep 2021;11:2415. [PMID: 33510294 DOI: 10.1038/s41598-021-82058-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Abou-fadel J, Reid V, Le A, Croft J, Zhang J. Key Members of the CmPn as Biomarkers Distinguish Histological and Immune Subtypes of Hepatic Cancers. Diagnostics 2023;13:1012. [DOI: 10.3390/diagnostics13061012] [Reference Citation Analysis]
2 Cheng HY, Ho CM, Hsiao CY, Ho MC, Wu YM, Lee PH, Hu RH. Interval dynamics of transplantability for hepatocellular carcinoma after primary curative resection: risk factors for nontransplantable recurrence. HPB (Oxford) 2023;25:218-28. [PMID: 36376221 DOI: 10.1016/j.hpb.2022.10.010] [Reference Citation Analysis]
3 Criss CR, Makary MS. Salvage locoregional therapies for recurrent hepatocellular carcinoma. World J Gastroenterol 2023; 29(3): 413-424 [PMID: 36688022 DOI: 10.3748/wjg.v29.i3.413] [Reference Citation Analysis]
4 Shin SK, Ryu S, Nam S, Ha SY, Kwon OS, Kim YS, Kim SH, Kim JH. Clinical Significance of Combined Epithelial-Mesenchymal Transition Markers Expression and Role of Rac1 in Hepatocellular Carcinoma. Int J Mol Sci 2023;24:1765. [PMID: 36675278 DOI: 10.3390/ijms24021765] [Reference Citation Analysis]
5 Wu ZQ, Cheng J, Xiao XX, Zhang HR, Wang J, Peng J, Liu C, Cai P, Li XM. Preoperative prediction of early recurrence of HBV-related hepatocellular carcinoma (≤5 cm) by visceral adipose tissue index. Front Surg 2022;9:985168. [PMID: 36684155 DOI: 10.3389/fsurg.2022.985168] [Reference Citation Analysis]
6 Wang X, Fu Y, Zhu C, Hu X, Zou H, Sun C. New insights into a microvascular invasion prediction model in hepatocellular carcinoma: A retrospective study from the SEER database and China. Front Surg 2022;9:1046713. [PMID: 36684226 DOI: 10.3389/fsurg.2022.1046713] [Reference Citation Analysis]
7 Yue Q, Zhou Z, Zhang X, Xu X, Liu Y, Wang K, Liu Q, Wang J, Zhao Y, Yin Y. Contrast-enhanced CT findings-based model to predict MVI in patients with hepatocellular carcinoma. BMC Gastroenterol 2022;22:544. [PMID: 36577952 DOI: 10.1186/s12876-022-02586-2] [Reference Citation Analysis]
8 Li S, Mei J, Cheng Y, Li Q, Wang Q, Fang C, Lei Q, Huang H, Cao M, Luo R, Deng J, Jiang Y, Zhao R, Lu L, Zou J, Deng M, Lin W, Guan R, Wen Y, Li J, Zheng L, Guo Z, Ling Y, Chen H, Zhong C, Wei W, Guo R. Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With FOLFOX in Hepatocellular Carcinoma With Microvascular Invasion: A Multicenter, Phase III, Randomized Study. JCO 2022. [DOI: 10.1200/jco.22.01142] [Reference Citation Analysis]
9 Wu G, Li J, Li C, Ou X, Feng K, Xia F, Chen Z, Zhang L, Ma K. Long‐term efficacy of no‐touch radiofrequency ablation in the treatment of single small hepatocellular carcinoma: A single center long‐term follow‐up study. Cancer Medicine 2022. [DOI: 10.1002/cam4.5428] [Reference Citation Analysis]
10 Sim JZT, Hui TCH, Chuah TK, Low HM, Tan CH, Shelat VG. Efficacy of texture analysis of pre-operative magnetic resonance imaging in predicting microvascular invasion in hepatocellular carcinoma. World J Clin Oncol 2022; 13(11): 918-928 [DOI: 10.5306/wjco.v13.i11.918] [Reference Citation Analysis]
11 Abou-fade J, Reid V, Le A, Zhang J. Differential expression of key CmPn members distinguishes histological and immune subtypes of hepatic cancers. Qeios 2022. [DOI: 10.32388/ufk906] [Reference Citation Analysis]
12 Aboelezz Ahmad AF, Elsawy AA, Omar HM, Abofrekha MH, Gabr MT. The role of shear wave elastography in differentiation between benign and malignant portal vein thrombosis in hepatocellular carcinoma. Egypt J Radiol Nucl Med 2022;53:188. [DOI: 10.1186/s43055-022-00872-3] [Reference Citation Analysis]
13 Akbulut S, Sahin TT, Ince V, Yilmaz S. Impact of COVID-19 pandemic on clinicopathological features of transplant recipients with hepatocellular carcinoma: A case-control study. World J Clin Cases 2022; 10(15): 4785-4798 [DOI: 10.12998/wjcc.v10.i15.4785] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
14 Xu X, Sun S, Liu Q, Liu X, Wu F, Shen C. Preoperative application of systemic inflammatory biomarkers combined with MR imaging features in predicting microvascular invasion of hepatocellular carcinoma. Abdom Radiol (NY) 2022;47:1806-16. [PMID: 35267069 DOI: 10.1007/s00261-022-03473-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Lee SJ, Kim M, Kwak YK, Kang HJ. MRI-guided radiotherapy for PVTT in HCC patients: evaluation of the efficacy and safety. J Cancer Res Clin Oncol 2021. [PMID: 34490584 DOI: 10.1007/s00432-021-03788-z] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
16 Mao S, Yu X, Yang Y, Shan Y, Mugaanyi J, Wu S, Lu C. Preoperative nomogram for microvascular invasion prediction based on clinical database in hepatocellular carcinoma. Sci Rep 2021;11:13999. [PMID: 34234239 DOI: 10.1038/s41598-021-93528-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]